ClinicalTrials.gg
RecruitingNCT07659314VAGANALUpdated Oct 29, 2026

Post Operative Pain and Vagal Stimulation

An interventional study of Experimental arm and Control arm in Rectal Surgery, Pain (Visceral, Somatic, or Neuropathic) and Vagal Nerve Stimulation, sponsored by University Hospital, Angers. Recruiting at 1 site in France. Open to participants aged 18 Years to 120 Years. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by University Hospital, Angers · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Oct 29, 2026Now RecruitingStart date moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 120 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 482 studies in Pain with a site in France — 75 open to participants now, 79 under way, 8 of them phase 3. Pain · France.

Planned enrollment
245th of 369
50 · median 80
Started
2026
with 27 others
No phase
225 of 482
50 open now
Primary completion
2027-10
later than 52 of 78 live
Registered
473rd of 482
by date

Among the 482 studies in Pain with a site in France, this one is the 245th largest by planned enrollment of the 369 interventional ones that give a count, is one of 28 that started in 2026, is one of 225 with no phase, reaches primary completion later than 52 of the 78 other live ones, and was the 473rd registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

75 of the 482 studies in Pain with a site in France are open now. Recruiting first, the newest first:

69 more — sign in →

All 75 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years to 120 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 482 studies in Pain with a site in France, or all of them as a file.
02

Study summary

Anorectal surgery is a type of surgery that can cause anal pain, particularly in the context of hemorrhoid surgery or anal fissure surgery. Generally, the period of discomfort related to the pain lasts about two weeks. There is a nerve (the vagus nerve) whose stimulation via a probe placed in the ear can reduce stress and chronic pain. Its ease of use makes it a promising tool for treating pain. Vagal auricular stimulation could be an interesting option in the management of postoperative pain of the anus and rectum. Its efficacy or feasibility in this context has never been evaluated.

The aim of this study is to evaluate the feasibility in this context and to assess the extend of pain reduction associated with perioperative nerve vagus stimulation by a medical device (Transcutaneous Electrical Nerve Stimulator (TENS ECO Plus)). It is offered to adult patients undergoing transanal anal or rectal surgery on an outpatient or inpatient basis as part of a scheduled procedure.

Patients to be included in the study are selected during the initial pre-operative consultation with the surgeon. Once the surgical indication is confirmed and the patient fulfills the study eligibility criteria, the investigator provides them with oral information about the study. The patient is also given an information sheet (written in language understandable to the patient) and a consent form.

During this initial visit, demographic data and information regarding the surgical indication are collected.

Stimulation begins two days before surgery (twice daily), followed by stimulation on the morning of surgery, one hour before arrival in the operating room. Successful completion of the stimulation, as well as any complications, are recorded in the patient diary.

On the day of surgery (day 0), data concerning the procedure and the maximum visual analogue scale (VAS) are collected in the recovery room. Analgesic consumption is also recorded.

On the evening of the procedure, stimulation is performed and adherence is recorded.

Maximum and mean VAS are collected on postoperative day 1 and then daily in the patient diary for 15 days.

Vagus nerve stimulation is performed morning and evening for 15 days. VAS scores, adherence, analgesic consumption, the date of the first bowel movement and its painfulness, as well as any complications related to the stimulation are noted in the patient diary. On day 3 (+/- 2 days) after the procedure, and at the end of the 15-day postoperative period, the patient will be contacted by phone or text message by the investigator team to remind them to complete the notebook.

On day 30 (+/- 5 days), the patient returns for a follow-up visit. The patient diary and equipment are collected. Complications are recorded, as well as quality of life during the postoperative month (SF-36 form).

For patients, the expected benefits are significant, as postoperative quality of life is expected to improve through reduced pain. Furthermore, decreasing the use of step II and III analgesics should shorten the recovery period and promote better overall recovery.

03

Conditions studied

  • Rectal Surgery
  • Pain (Visceral, Somatic, or Neuropathic)
  • Vagal Nerve Stimulation

Browse trials for

04

Who can participate

Ages eligible
18 Years to 120 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Adult patient
  • Underwent anal or rectal surgery via the transanal route
  • Managed on an outpatient basis or in conventional hospitalization
  • Having signed a consent to participate in the study

Exclusion Criteria:

  • Patient operated on as an emergency
  • Rectal surgery via abdominal approach or requiring an abdominal approach during the procedure
  • Known epileptic patient
  • Patient with a pacemaker
  • Patient refusing to participate in the study
  • Pregnant, breastfeeding, or laboring woman
  • Patient not affiliated with a social security scheme
  • Person deprived of liberty by judicial or administrative decision
  • Person subject to compulsory psychiatric care - Any mentioned in the instructions for use of the medical device under investigation

Exclusion Criteria:

  • Unscheduled conversion from the transanal route to the abdominal route during surgery
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    active nerve vagus stimulator

    assessment of rectal post operative pain with active nerve vagus stimulation

    Device: Experimental arm

  • Sham comparator
    control arm

    assessment of rectal post operative pain without active nerve vagus stimulation

    Device: Control arm

Interventions

  • DeviceExperimental arm

    active vagus nerve stimulation

  • DeviceControl arm

    no active vagus nerve stimulation

06

What researchers measure

Primary outcomes

  1. Change of pain after perioperative auricular vagus nerve stimulation

    The intensity of anal pain is measured by the Visual Analog Scale (VAS) from 0 to 10 in the recovery room and then every day for 15 days. This VAS is assessed in patients treated with auricular vagus active nerve stimulation and in patients with a inactive device. The higher score means a worse outcome.

    Time frame: day 0, day 1, day 2, day 3, day 4, day 5, day 6, day 7, day 8, day 9, day 10, day 11, day 12, day 13, day 14, day 15

  2. consumption of analgesic

    the post-operative consumption of analgesic is evaluated in the recovery room (day 0) and then every day for 15 days. Post-operative consumption is assessed in patients treated with auricular vagus active nerve stimulation and in patients with a inactive device.

    Time frame: From Day 0 to Day 15

Secondary outcomes

  1. Delay in gastrointestinal motility recovery (passage of stool) and post-defecatory pain

    The gastrointestinal transit recovery after surgery is recorded in the patients treated with active device and in patients treated with inactive device. Post defecatory pain more than 30 min is also reported in the patients with active and with inactive device.

    Time frame: from day 0 to day 30

  2. Quality of life of patients after surgery

    quality of life by health survey SF 36 (the 36-item Short Form Health Survey) is assessed at the day 30 after surgery in the two groups of patients (active device and no active device). SF 36 covers eight health domains: physical functioning (10 items), bodily pain (2 items), role limitations due to physical health problems (4 items), role limitations due to personal or emotional problems (4 items), emotional well-being (5 items), social functioning (2 items), energy/fatigue (4 items), and general health perceptions (5 items). Scores for each domain range from 0 to 100, with a higher score defining a more favorable health state.

    Time frame: Day 30

  3. adverse events

    adverse events occuring during the first month after surgery and specifically related to the surgery are collected by the investigator for the two groups of patients

    Time frame: day 30

  4. acceptability of perioperative auricular vagus nerve stimulation by the patient

    The acceptability of treatment by perioperative auricular vagal stimulation is assessed at day 15 by asked question to the two groups of patients. The question is "do you think that the treatment with vagus nerve stimulation is non-binding?"

    Time frame: day 15

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Oct 2027, 12 months after the start.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 12 months is above that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 29, 2026: start Nov 2026 → Oct 2026, primary completion Nov 2027 → Oct 2027 and completion Jan 2028 → Mar 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 15, 2026
First posted
Jun 22, 2026
StartActual
Oct 21, 2026was Nov 2026
Primary completionEst.
Oct 21, 2027was Nov 2027
CompletionEst.
Mar 21, 2028was Jan 2028
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 29, 2026
Sites
1 site added, 1 site removed
Show site
  • HU Angers · Angers, France
Show 1 removed
  • Angers Hospital · Angers, France
Oct 29, 2026
Start date
Nov 9, 2026→Oct 21, 2026 (actual)
Oct 29, 2026
Primary completion
Nov 9, 2027→Oct 21, 2027
Oct 29, 2026
Study completion
Jan 9, 2028→Mar 21, 2028
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    Not yet recruiting→Recruiting
    1 site added, 1 site removed
    Show site
    • HU Angers · Angers, France
    Show 1 removed
    • Angers Hospital · Angers, France
    Start date Nov 9, 2026→Oct 21, 2026 (now actual)
    Primary completion Nov 9, 2027→Oct 21, 2027
    Study completion Jan 9, 2028→Mar 21, 2028

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07659314
Responsible party
Sponsor
First posted
Jun 22, 2026
Start date
Oct 21, 2026
Primary completion
Oct 21, 2027 (estimated)
Completion
Mar 21, 2028 (estimated)
Last update
Oct 29, 2026

Study contacts

Sarfati Marine, MD
Contact
Marine.SarfatiLebreton@chu-angers.fr
+33 2 41 35 36 17

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion